Lemzoparlimab, a Differentiated Anti-CD47 Antibody in Combination with Rituximab in Relapsed and Refractory Non-Hodgkin's Lymphoma: Initial Clinical ResultsAmitkumar Mehta,Wael Harb, Claire Xu,Yuan Meng,Linda Lee, Vivian Yuan,Zhengyi Wang, Pengfei Song,Joan Huaqiong Shen,Ajay K GopalBlood（2021）引用 13|浏览6暂无评分摘要Introduction更多查看译文AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
